Headlines about Danaher (NYSE:DHR) have trended somewhat positive this week, according to Accern Sentiment. The research firm identifies positive and negative press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Danaher earned a media sentiment score of 0.14 on Accern’s scale. Accern also assigned news articles about the conglomerate an impact score of 46.6717824123663 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
These are some of the media stories that may have impacted Accern’s scoring:
- Global Dental Devices Market 2018 by key Venders – Danaher, Straumann, Dentsply, Zimmer (healthcaretrends24.com)
- Danaher Corporation, (NYSE: DHR) – May This Data Fuel Up Investor’s Confidence (stocksnewstimes.com)
- RF Spectrum Analyzer Market Global Overview 2018- Danaher, National Instruments, Kaltman Creations (businessservices24.com)
- Danaher Corporation (NYSE:DHR) – An Eye on Data (nasdaqjournal.com)
- Global Dental Consumables and Dental Equipments Market 2018 – Dentsply Sirona, Danaher, Align Technology … (digitaljournal.com)
DHR has been the topic of several research analyst reports. Credit Suisse Group reiterated a “hold” rating and issued a $99.00 target price on shares of Danaher in a research report on Tuesday, December 19th. Zacks Investment Research lowered shares of Danaher from a “buy” rating to a “hold” rating in a research report on Tuesday, December 19th. Robert W. Baird reiterated a “buy” rating on shares of Danaher in a research report on Friday, January 12th. Barclays initiated coverage on shares of Danaher in a research report on Thursday, February 15th. They issued an “overweight” rating and a $110.00 target price on the stock. Finally, Royal Bank of Canada reiterated a “hold” rating and issued a $96.00 target price on shares of Danaher in a research report on Thursday, January 4th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the stock. Danaher currently has a consensus rating of “Buy” and a consensus price target of $102.23.
Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.16 by $0.03. The firm had revenue of $5.09 billion for the quarter, compared to analyst estimates of $4.97 billion. Danaher had a net margin of 13.60% and a return on equity of 11.36%. Danaher’s quarterly revenue was up 10.9% on a year-over-year basis. During the same period in the previous year, the business posted $1.05 earnings per share. analysts predict that Danaher will post 4.38 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Thursday, March 29th will be paid a dividend of $0.16 per share. The ex-dividend date of this dividend is Wednesday, March 28th. This is an increase from Danaher’s previous quarterly dividend of $0.14. This represents a $0.64 dividend on an annualized basis and a yield of 0.67%. Danaher’s payout ratio is 15.88%.
In other Danaher news, SVP Angela S. Lalor sold 42,988 shares of Danaher stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $102.29, for a total transaction of $4,397,242.52. Following the transaction, the senior vice president now directly owns 82,008 shares of the company’s stock, valued at $8,388,598.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Rainer Blair sold 51,080 shares of Danaher stock in a transaction dated Wednesday, February 21st. The stock was sold at an average price of $97.26, for a total transaction of $4,968,040.80. Following the transaction, the insider now directly owns 50,477 shares in the company, valued at $4,909,393.02. The disclosure for this sale can be found here. Insiders have sold 313,260 shares of company stock worth $31,657,786 over the last ninety days. 12.20% of the stock is owned by insiders.
TRADEMARK VIOLATION NOTICE: This news story was posted by WKRB News and is the sole property of of WKRB News. If you are viewing this news story on another site, it was copied illegally and reposted in violation of United States & international copyright & trademark legislation. The original version of this news story can be viewed at https://www.wkrb13.com/2018/04/03/danaher-dhr-receiving-somewhat-favorable-media-coverage-report-finds.html.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.